Impact of offering blood-based testing alongside existing modalities for colorectal cancer screening among those who previously declined screening: an economic evaluation.

Full Text Links

Authors

Abstract

Inadequate adherence to colorectal cancer screening reduces individual and population level health benefits. Blood-based tests offer a new modality that may help patients overcome barriers, but there are concerns about the impact of patients switching from existing guideline-recommended screening modalities. This study estimates the population health outcomes and cost-effectiveness of offering blood-based testing using a validated individual-level simulation model based on patient preference evidence from randomized controlled trials.

Keywords: C63, I19, Liquid biopsy, adherence, blood-based, colorectal cancer, cost-effectiveness analysis, patient preferences, screening, simulation

Source

Journal of medical economics

Publication Type

Journal Article

Language

English

PubMed ID

41764032

MeSH terms